Microparticles and cardiovascular diseases

被引:44
作者
Voukalis, Christos [1 ]
Shantsila, Eduard [1 ]
Lip, Gregory Y. H. [2 ,3 ,4 ]
机构
[1] Univ Birmingham, Inst Cardiovasc Sci, Birmingham, W Midlands, England
[2] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England
[3] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England
[4] Aalborg Univ, Aalborg Thrombosis Res Unit, Dept Clin Med, Aalborg, Denmark
关键词
Microparticles; cardiovascular; inflammation; thrombosis; atherosclerosis; heart failure; PLATELET-DERIVED MICROPARTICLES; CIRCULATING ENDOTHELIAL MICROPARTICLES; TYPE-2; DIABETES-MELLITUS; HUMAN ATHEROSCLEROTIC PLAQUES; HEART-FAILURE PATIENTS; MYOCARDIAL-INFARCTION PATIENTS; SHED MEMBRANE MICROPARTICLES; MONOCYTE ACTIVATION MARKERS; TISSUE FACTOR ACTIVITY; ACUTE ISCHEMIC-STROKE;
D O I
10.1080/07853890.2019.1609076
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Microparticles are a distinctive group of small vesicles, without nucleus, which are involved as significant modulators in several physiological and pathophysiological mechanisms. Plasma microparticles from various cellular lines have been subject of research. Data suggest that they are key players in development and manifestation of cardiovascular diseases and their presence, in high levels, is associated with chronic inflammation, endothelial damage and thrombosis. The strong correlation of microparticle levels with several outcomes in cardiovascular diseases has led to their utilization as biomarkers. Despite the limited clinical application at present, their significance emerges, mainly because their detection and enumeration methods are improving. This review article summarizes the evidence derived from research, related with the genesis and the function of microparticles in the presence of various cardiovascular risk factors and conditions. The current data provide a substrate for several theories of how microparticles influence various cellular mechanisms by transferring biological information.
引用
收藏
页码:193 / 223
页数:31
相关论文
共 50 条
  • [21] Resveratrol and Cardiovascular Diseases
    Bonnefont-Rousselot, Dominique
    NUTRIENTS, 2016, 8 (05)
  • [22] Iron and cardiovascular diseases
    Naito, Yoshiro
    Masuyama, Tohru
    Ishihara, Masaharu
    JOURNAL OF CARDIOLOGY, 2021, 77 (02) : 160 - 165
  • [23] Microparticles, Vascular Function, and Atherothrombosis
    Rautou, Pierre-Emmanuel
    Vion, Anne-Clemence
    Amabile, Nicolas
    Chironi, Gilles
    Simon, Alain
    Tedgui, Alain
    Boulanger, Chantal M.
    CIRCULATION RESEARCH, 2011, 109 (05) : 593 - 606
  • [24] The Many Faces of Endothelial Microparticles
    Dignat-George, Francoise
    Boulanger, Chantal M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (01) : 27 - 33
  • [25] Microparticles as Regulators of Cardiovascular Inflammation
    Andriantsitohaina, Ramaroson
    Gaceb, Abderahim
    Vergori, Luisa
    Martinez, M. Carmen
    TRENDS IN CARDIOVASCULAR MEDICINE, 2012, 22 (04) : 88 - 92
  • [26] Therapeutic Perspectives of Adenosine Deaminase Inhibition in Cardiovascular Diseases
    Kutryb-Zajac, Barbara
    Mierzejewska, Paulina
    Slominska, Ewa M.
    Smolenski, Ryszard T.
    MOLECULES, 2020, 25 (20):
  • [27] Role of Epicardial Adipose Tissue in Cardiovascular Diseases: A Review
    Konwerski, Michal
    Gasecka, Aleksandra
    Opolski, Grzegorz
    Grabowski, Marcin
    Mazurek, Tomasz
    BIOLOGY-BASEL, 2022, 11 (03):
  • [28] Circulating microparticles in renal diseases
    Daniel, Laurent
    Dou, Laetitia
    Berland, Yvon
    Lesavre, Philippe
    Mecarelli-Halbwachs, Lise
    Dignat-George, Francoise
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (07) : 2129 - 2132
  • [29] A review of studies of the proteomes of circulating microparticles: key roles for galectin-3-binding protein-expressing microparticles in vascular diseases and systemic lupus erythematosus
    Nielsen, Christoffer T.
    Ostergaard, Ole
    Rasmussen, Niclas S.
    Jacobsen, Soren
    Heegaard, Niels H. H.
    CLINICAL PROTEOMICS, 2017, 14
  • [30] Circulating cell-derived microparticles as biomarkers in cardiovascular disease
    Thulin, Asa
    Christersson, Christina
    Alfredsson, Jenny
    Siegbahn, Agneta
    BIOMARKERS IN MEDICINE, 2016, 10 (09) : 1009 - 1022